2nd IBC-IC : An unmissable event in the fight against inflammatory breast cancer
The 2nd IBC-IC will bring together experts from Tunisia, North Africa, the United States, and Europe in Tunis to review the latest advances in research and clinical trials related to inflammatory breast cancer, a rare and aggressive form of the disease.
More than just a scientific conference, this event aims to be a true meeting and inspiration hub. In a warm and collegial atmosphere, it will foster the exchange of ideas, enriching discussions, and the creation of lasting collaborations between researchers, clinicians, and oncology professionals.
ScreenCell® will be present at IBC-IC 2025 at Stand No. 4
During IBC-IC 2025, ScreenCell® will have the opportunity to present its liquid biopsy technology dedicated to the isolation of circulating tumor cells (CTC), through two key moments:
- A dedicated stand (Stand No. 4) in the exhibition area, where our team will showcase ScreenCell® technology.
- An oral presentation as part of the scientific program, on May 10th from 3:10 PM to 3:30 PM, during which we will detail the clinical and research applications of our technology, particularly in the context of inflammatory breast cancer.
Meet our team at IBC-IC.
The ScreenCell® team is excited to participate in the scientific discussions at the 2nd IBC-IC. We invite you to meet our experts throughout the event to discover how our technology can contribute to advancements in the understanding and treatment of inflammatory breast cancer.
